Stock Track | Tempus AI Soars 5.01% Intraday as Median Technologies Partnership with Canon Highlights AI Healthcare Ties

Stock Track

07/31

Tempus AI (TEM) shares surged 5.01% during intraday trading on Thursday, as the medical AI company benefited from positive sentiment surrounding a new partnership in the diagnostic AI space.

The rally was fueled by an announcement from Median Technologies, which revealed a global commercialization agreement with Canon Medical Systems’ Olea Medical unit for its eyonis LCS lung cancer screening software. The news highlighted Median’s multi-channel go-to-market strategy, which notably includes an earlier strategic tie-up with Tempus AI. Investors viewed the expanding ecosystem of AI-driven diagnostics as a strong validation of the sector, lifting shares of Tempus AI in sympathy with the broader industry momentum.

The movement reflects growing confidence in collaborative efforts within the medical AI landscape, as companies like Tempus AI continue to form key alliances to advance precision medicine and diagnostics.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/news/1126339393"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1126339393\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1126339393?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-31 03:40","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1126339393","market":"sg","top_or_hot":-1,"title":"Stock Track | Tempus AI Soars 5.01% Intraday as Median Technologies Partnership with Canon Highlights AI Healthcare Ties","media":"Stock Track","content":"<p>Tempus AI (TEM) shares surged 5.01% during intraday trading on Thursday, as the medical AI company benefited from positive sentiment surrounding a new partnership in the diagnostic AI space.</p><p>The rally was fueled by an announcement from Median Technologies, which revealed a global commercialization agreement with Canon Medical Systems’ Olea Medical unit for its eyonis LCS lung cancer screening software. The news highlighted Median’s multi-channel go-to-market strategy, which notably includes an earlier strategic tie-up with Tempus AI. Investors viewed the expanding ecosystem of AI-driven diagnostics as a strong validation of the sector, lifting shares of Tempus AI in sympathy with the broader industry momentum.</p><p>The movement reflects growing confidence in collaborative efforts within the medical AI landscape, as companies like Tempus AI continue to form key alliances to advance precision medicine and diagnostics.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Tempus AI Soars 5.01% Intraday as Median Technologies Partnership with Canon Highlights AI Healthcare Ties</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Tempus AI Soars 5.01% Intraday as Median Technologies Partnership with Canon Highlights AI Healthcare Ties\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time smaller\">2026-07-31 03:40</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Tempus AI (TEM) shares surged 5.01% during intraday trading on Thursday, as the medical AI company benefited from positive sentiment surrounding a new partnership in the diagnostic AI space.</p><p>The rally was fueled by an announcement from Median Technologies, which revealed a global commercialization agreement with Canon Medical Systems’ Olea Medical unit for its eyonis LCS lung cancer screening software. The news highlighted Median’s multi-channel go-to-market strategy, which notably includes an earlier strategic tie-up with Tempus AI. Investors viewed the expanding ecosystem of AI-driven diagnostics as a strong validation of the sector, lifting shares of Tempus AI in sympathy with the broader industry momentum.</p><p>The movement reflects growing confidence in collaborative efforts within the medical AI landscape, as companies like Tempus AI continue to form key alliances to advance precision medicine and diagnostics.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TEM","symbol_name":"Tempus AI","start_time":0,"source_url":"","article_id":"1126339393","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1126339393","pubTimestamp":1785440424,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Tempus AI (TEM) shares surged 5.01% during intraday trading on Thursday, as the medical AI company benefited from positive sentiment surrounding a new partnership in the diagnostic AI space.The rally...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"TEM":"Tempus AI"},"translate_title":"股票跟踪 | Median Technologies 与佳能的合作伙伴关系凸显人工智能医疗保健关系，腾邦人工智能盘中飙升 5.01%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TEM":1},"content_text":"Tempus AI (TEM) shares surged 5.01% during intraday trading on Thursday, as the medical AI company benefited from positive sentiment surrounding a new partnership in the diagnostic AI space.The rally was fueled by an announcement from Median Technologies, which revealed a global commercialization agreement with Canon Medical Systems’ Olea Medical unit for its eyonis LCS lung cancer screening software. The news highlighted Median’s multi-channel go-to-market strategy, which notably includes an earlier strategic tie-up with Tempus AI. Investors viewed the expanding ecosystem of AI-driven diagnostics as a strong validation of the sector, lifting shares of Tempus AI in sympathy with the broader industry momentum.The movement reflects growing confidence in collaborative efforts within the medical AI landscape, as companies like Tempus AI continue to form key alliances to advance precision medicine and diagnostics.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}